Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$388M |
| 2 |
Spotify
SPOT
|
+$356M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$222M |
| 5 |
Wayfair
W
|
+$205M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$499M |
| 2 |
MarketAxess Holdings
MKTX
|
+$320M |
| 3 |
Visa
V
|
+$276M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$244M |
| 5 |
BLUE
bluebird bio
BLUE
|
+$232M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 34.47% |
| 2 | Healthcare | 16.47% |
| 3 | Communication Services | 15.64% |
| 4 | Technology | 12.03% |
| 5 | Financials | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Zai Lab
ZLAB
$2.08B
| $126M | 0.12% |
3,039,700
-96,400
| -3% | -$3.56M |
|
|
SFIX
102
Stitch Fix
SFIX
$571M
| $121M | 0.12% |
4,724,391
+241,532
| +5% | +$5.61M |
|
103
DNOW Inc
DNOW
$2.62B
| $118M | 0.11% |
10,519,170
-5,779,793
| -35% | -$64.5M |
|
104
HEICO Corp Class A
HEI.A
$37.4B
| $111M | 0.11% |
1,239,184
+24,100
| +2% | +$2.3M |
|
|
ATVI
105
DELISTED
Activision Blizzard
ATVI
| $110M | 0.11% |
1,849,922
-59,441
| -3% | -$3.29M |
|
|
PLAN
106
DELISTED
Anaplan, Inc.
PLAN
| $98.1M | 0.09% |
1,871,644
| – | – |
|
|
NEWR
107
DELISTED
New Relic, Inc.
NEWR
| $86.1M | 0.08% |
1,309,695
+70,847
| +6% | +$4.6M |
|
108
Sea Limited
SE
$69.3B
| $82.2M | 0.08% |
2,043,646
+94,232
| +5% | +$3.17M |
|
109
Fastenal
FAST
$57.8B
| $79.3M | 0.08% |
4,291,004
-10,750
| -0.2% | -$192K |
|
110
MakeMyTrip
MMYT
$5.77B
| $75.7M | 0.07% |
3,306,787
+100,065
| +3% | +$2.42M |
|
111
Petrobras Class A
PBR.A
$107B
| $70.8M | 0.07% |
4,743,773
+141,334
| +3% | +$2M |
|
112
STAAR Surgical
STAA
$1.16B
| $68.3M | 0.07% |
1,942,929
+34,641
| +2% | +$1.14M |
|
113
Moderna
MRNA
$23.3B
| $66.8M | 0.06% |
3,416,113
+201,316
| +6% | +$3.57M |
|
|
EXAS
114
DELISTED
Exact Sciences
EXAS
| $66.6M | 0.06% |
720,494
+103,524
| +17% | +$9.1M |
|
115
Coca-Cola
KO
$373B
| $64.5M | 0.06% |
1,165,472
+11,184
| +1% | +$601K |
|
|
EB
116
DELISTED
Eventbrite
EB
| $62.9M | 0.06% |
3,117,611
+169,344
| +6% | +$3.24M |
|
117
Pacira BioSciences
PCRX
$1.02B
| $62.9M | 0.06% |
1,387,445
+235,735
| +20% | +$10M |
|
|
JMIA
118
Jumia Technologies
JMIA
$747M
| $62.2M | 0.06% |
9,242,106
+235,008
| +3% | +$1.48M |
|
|
BLUE
119
DELISTED
bluebird bio
BLUE
| $61M | 0.06% |
53,701
-213,088
| -80% | -$232M |
|
120
Procter & Gamble
PG
$340B
| $60.7M | 0.06% |
485,952
+1,742
| +0.4% | +$213K |
|
121
Codexis
CDXS
$155M
| $60.6M | 0.06% |
3,788,034
+516,934
| +16% | +$7.65M |
|
|
SPLK
122
DELISTED
Splunk Inc
SPLK
| $52.9M | 0.05% |
353,377
+14,088
| +4% | +$1.85M |
|
123
Trupanion
TRUP
$1.06B
| $51.6M | 0.05% |
1,377,130
+32,268
| +2% | +$948K |
|
124
AeroVironment
AVAV
$8.62B
| $50.5M | 0.05% |
817,695
+22,049
| +3% | +$1.32M |
|
125
PepsiCo
PEP
$189B
| $50.5M | 0.05% |
369,340
+6,203
| +2% | +$844K |
|
Similar funds
Baillie Gifford & Co's Q4 2019 Portfolio in Review
As of Q4 2019, Baillie Gifford & Co held 230 positions worth $103B, up 18% from $87.9B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3.9%. Baillie Gifford & Co opened 5 new positions and exited 4, leaving the 230-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Communication Services.
- Baillie Gifford & Co's largest Q4 2019 buy was LiveRamp: 803,200 shares worth $38.6M.
- Baillie Gifford & Co added most to Alibaba in Q4 2019, an estimated $388M increase.
- Baillie Gifford & Co's biggest Q4 2019 reduction was Baidu, cutting an estimated $499M.
- Baillie Gifford & Co fully exited Spectrum Brands in Q4 2019, selling an estimated $17.7M.
- Baillie Gifford & Co's ten largest holdings make up 47% of its $103B portfolio in Q4 2019.
- Baillie Gifford & Co opened 5 new positions and closed 4 in Q4 2019.
- Baillie Gifford & Co's portfolio value rose 18% quarter-over-quarter to $103B.
Based on Baillie Gifford & Co's 13F filing for Q4 2019, filed 10 Feb 2020.